Company / R&D per Share
ARVINAS, INC. R&D per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$4.15
FY2025
5-year range
$1.39 / $7.14
FY2021-FY2025
Trend
-19.0%
vs FY2024
Sector context
#49 of 208
Health Care
What the data says
ARVINAS, INC.'s r&d per share of $4.15 is higher than 76% of companies in the Health Care sector (FY2025). R&D per Share has fluctuated over the past 9 years, ranging from $1.39 in FY2021 to $15.17 in FY2017.
Based on SEC 10-K filings.
4.15 in FY2025 with a 5-year CAGR of +8.0%. Top quartile in the Health Care sector.
Declined from $7.14 to $4.15 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +26.6%
- 5-Year CAGR
- +8.0%
- 10-Year CAGR
- -
Sector benchmark
Top 24% in Health CareTop 24% of 208This company $4.15 Sector average $28.82
▼
-85.6% below sector average
Key checks
Key Insights
- In FY2025, r&d per share decreased 19.0% year-over-year.
- Ranks #49 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2017.
- Lowest r&d per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.85 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.15 | -19.0% |
| FY2024 | $5.12 | -28.3% |
| FY2023 | $7.14 | +249.0% |
| FY2022 | $2.05 | +47.6% |
| FY2021 | $1.39 | -50.8% |
| FY2020 | $2.82 | +94.8% |
| FY2019 | $1.45 | +0.0% |
| FY2018 | $1.45 | -90.5% |
| FY2017 | $15.17 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026